Article
New Orleans - Results from blinded studies demonstrate the facial skin benefits of cosmeceuticals containing the tripeptide-copper complex glycyl-L-L-histidyl-CU (GHK-Cu), James J. Leyden, M.D., reported at the annual meeting of the American Academy of Dermatology.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.